🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In KN A18, CCRT+ pembrolizumab vs SOC (CCRT) improved PFS and OS in locally advanced cervical cancer. #ESMO2024 OncoAlert Omar Abdihamid ESMO - Eur. Oncology

Institut Curie France tv Je crois que Institut Curie a un petit problème de type "stagiaire BFM"

Quitting smoking after a cancer diagnosis significantly increases survival, regardless of cancer type The sooner you quit, the better: Those who quit within 3 months of diagnosis had a 25% lower risk of death, 6 months = 21% lower, and 9 months = 15% lower. 75th percentile

This prospective-retrospective translational study of patients enrolled in SOFT was the first study in which a genomic assay was able to predict which premenopausal patients were most likely to benefit from ovarian function suppression. ja.ma/3Uu7gq6

WHO Approves Another HPV Vaccine for Single-Dose Use Out on JAMA In October, the World Health Organization (WHO) prequalified Cecolin, a fourth HPV #vaccine, for single-dose use, following its 2022 recommendation to shift from a 2-dose to a 1-dose schedule to address global

Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive #BreastCancer out in JCO study aimed to develop a tool called RSClinN+ to personalize recurrence risk and chemotherapy benefit predictions

A new meta-analysis published this month in Annals suggests that patients treated by female surgeons have lower mortality than those treated by male surgeons. journals.lww.com/annalsofsurger…

HPV vaccines save lives! Cervical cancer mortality in US women <25 dropped 62% (2016-2021). Vaccination works! #HPV #CancerPrevention #VaccinationMatters JAMA Network Open OncoAlert Oncology Brothers jamanetwork.com/journals/jama/…

3 yrs since the MonarchE/axillary dissection debate!no clear consensus And you, what r u doing in clinical practice?? surgical revision for the total number of N+? pubmed.ncbi.nlm.nih.gov/35675571/ Sara Tolaney Dr. E Mittendorf Professor Stephen Johnston Kevin Kalinsky, MD, MS, FASCO Boston Breast Surgeon

Should go without saying, but good evidence about how impt consistent adherence to endocrine therapy is in terms of outcome, especially in very young. This is as large as our chemo benefit in some cases! Impt to explain to patients and help them with side effects. #SABCS24

Wrapping up another fantastic #SABCS! Amazing, practice-changing data were presented. I’ve updated the algorithms and added key studies from the meeting— I finally ran out of space in HR+ disease! #SABCS24 OncoAlert

🔪 Open 🔦 Laparoscopic 🤖 Robot Pancreatoduodenectomy Randomised Controlled Trials 🧮 Network Meta-Analysis on 7 RCT 1.3 K patients 🔦 LPD ⬇️ LOS and blood loss vs. OPD 🔪 OPD ⬇️ OR time vs. LPD 🤖 RPD similar OPD but data preliminary.. 🫵 Surprised? journals.lww.com/aosopen/fullte…

The #RELARC trial was highly-anticipated, but scarcely-discussed online when it was published this Fall. This was a massive effort from 17 hospitals in China that randomized >1000 patients with right-sided colon cancer to either CME or the more-traditional D2 dissection. They

2024 approvals: Summary of 8 new drugs/indications in #BreastCancer & #GynOnc by U.S. FDA 1. #Ribociclib 2. #Inavolisib 3. #Pembrolizumab x2 4. #Mirvetuximab 5. #Tisotumab 6. #Dostarlimab 7. #Durvalumab #bcsm #gyncsm #OncTwitter #MedTwitter #HappyHolidays

Same-day Ileostomy Closure Discharge Reduces Costs Without Compromising Outcomes: An Economic Analysis journals.lww.com/annalsofsurger…

Removal of normal appearing lymph nodes is a thing of the past for therapeutic value! Identifying nodal metastasis (SLN) is of value. But we need to stop thinking removing 50-100 normal nodes makes a difference. All it dose is cause morbidity

A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions: the MYometrial Lesion UltrasouNd And mRi study ajog.org/article/S0002-…

For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. ja.ma/426mLaK Henry Kuerer HelenMJohnsonMD Simona F. Shaitelman MD, EdM

Here are my top 10 for gynecologic cancers at #ASCO25 Can't wait to see you all there! Debra Richardson, M.D. Shannon Westin, MD, MPH, FASCO BJ Rimel Robert Wenham what are you excited to see?

Very important Insight at #ASCO25 >10% of ER -/low breast cancer patients had increased ER expression in residual tumors post-NAC ✅Retesting can unlock adjuvant endocrine therapy. ⬇️Don’t skip it if there’s residual disease! meetings.asco.org/abstracts-pres… #Oncology OncoAlert ASCO